Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy.
Amer M ZeidanJan Philipp BewersdorfVanessa HasleRory Michael ShallisEthan ThompsonDaniel Lopes de MenezesShelonidta RoseIsaac BossStephanie HaleneTorsten HaferlachBrian FoxPublished in: Leukemia (2022)